Gene · 1311
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Functions and Mechanisms of Tendon Stem/Progenitor Cells in Tendon Healing. | Stem Cells Int | 2023 | 37731626 | PubTator, text mining | PubMed |
| Cartilage and bone loss in premenopausal women with rheumatoid arthritis: Radiological and laboratory assessments. | Int J Rheum Dis | 2023 | 37731289 | PubTator, text mining | PubMed |
| The effects of a 6-month weight loss intervention on physical function and serum biomarkers in older adults with and without osteoarthritis. | Osteoarthr Cartil Open | 2023 | 37719442 | PubTator, text mining | PubMed |
| Regenerative medicine for early osteoarthritis. | Ther Adv Musculoskelet Dis | 2023 | 37694184 | PubTator, text mining | PubMed |
| Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities. | Int J Mol Sci | 2023 | 37685951 | PubTator, text mining | PubMed |
| Multiple Factors Involved in Bone Damage Caused by Chikungunya Virus Infection. | Int J Mol Sci | 2023 | 37685893 | PubTator, text mining | PubMed |
Ultrasound-Guided Injections of HYADD4 for Knee Osteoarthritis Improves Pain and Functional Outcomes at 3, 6, and 12 Months without Changes in Measured Synovial Fluid, Serum Collagen Biomarkers, or Most Synovial Fluid Biomarker Proteins at 3 Months. | J Clin Med | 2023 | 37685608 | PubTator, text mining | PubMed |
| What the pediatric endocrinologist needs to know about skeletal dysplasia, a primer. | Front Pediatr | 2023 | 37675393 | PubTator, text mining | PubMed |
| The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects. | Curr Rheumatol Rep | 2023 | 37656392 | PubTator, text mining | PubMed |
| Clinical features and morphology of collagen fibrils in patients with vascular Ehlers-Danlos based on electron microscopy. | Front Genet | 2023 | 37655064 | PubTator, text mining | PubMed |
| Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies. | Cell Mol Life Sci | 2023 | 37632572 | PubTator, text mining | PubMed |
| Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis. | J Clin Med | 2023 | 37629227 | PubTator, text mining | PubMed |
| The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis. | Int J Mol Sci | 2023 | 37628804 | PubTator, text mining | PubMed |
| Understanding Fibroblast Heterogeneity in Form and Function. | Biomedicines | 2023 | 37626760 | PubTator, text mining | PubMed |
| BHLHE40 Maintains the Stemness of PαS Cells In Vitro by Targeting Zbp1 through the Wnt/β-Catenin Signaling Pathway. | Biomedicines | 2023 | 37626688 | PubTator, text mining | PubMed |
| Adipocyte regulation of cancer stem cells. | Cancer Sci | 2023 | 37622414 | PubTator, text mining | PubMed |
| Low-oxygen tension augments chondrocyte sensitivity to biomimetic thermomechanical cues in cartilage-engineered constructs. | iScience | 2023 | 37599834 | PubTator, text mining | PubMed |
| Knowledge fields and emerging trends about extracellular matrix in carotid artery disease from 1990 to 2021: analysis of the scientific literature. | Eur J Med Res | 2023 | 37587506 | PubTator, text mining | PubMed |
| SPARC Is Highly Expressed in Young Skin and Promotes Extracellular Matrix Integrity in Fibroblasts via the TGF-β Signaling Pathway. | Int J Mol Sci | 2023 | 37569556 | PubTator, text mining | PubMed |
| Advances in epigenetic research of adolescent idiopathic scoliosis and congenital scoliosis. | Front Genet | 2023 | 37564871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1311/papers?page=10